The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cabazitaxel plus cisplatin coadministration and drug-interaction study in patients with advanced solid tumors.
Alain C. Mita
No relevant relationships to disclose
Shankar Sundaram
No relevant relationships to disclose
John Sarantopoulos
No relevant relationships to disclose
Monica M. Mita
No relevant relationships to disclose
Alex R. Lane
No relevant relationships to disclose
Jennifer L. Moseley
No relevant relationships to disclose
Devalingam Mahalingam
No relevant relationships to disclose
Benjamin R. Tan
No relevant relationships to disclose
Jean-Francois Dedieu
Employment or Leadership Position - Sanofi
Diane Stash
Employment or Leadership Position - Sanofi
Xin Zhi
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Florent Mazuir
Employment or Leadership Position - Sanofi
Albert C. Lockhart
Research Funding - Sanofi